161.23k followers • 16 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.How do we pick these stocks?
This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.How are these weighted?
The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|ABBV||AbbVie Inc.||142.6||+0.52||+0.37%||4:03 PM EDT||5.21M||6.15M||252.10B|
|BUD||Anheuser-Busch InBev SA/NV||54.89||+0.46||+0.85%||4:00 PM EDT||849.37k||1.28M||96.18B|
|MO||Altria Group, Inc.||45.15||+0.02||+0.04%||4:03 PM EDT||7.35M||11.25M||82.94B|
|TAP||Molson Coors Beverage Company||56.71||+0.01||+0.02%||4:03 PM EDT||1.08M||1.60M||12.33B|
|SMG||The Scotts Miracle-Gro Company||81.59||-0.42||-0.51%||4:00 PM EDT||458.86k||567.74k||4.49B|
|TLRY||Tilray Brands, Inc.||4.03||+0.18||+4.68%||4:00 PM EDT||23.37M||25.49M||1.91B|
|WEED.TO||Canopy Growth Corporation||4.19||+0.18||+4.49%||4:00 PM EDT||2.33M||2.62M||1.65B|
|CGC||Canopy Growth Corporation||3.3||+0.15||+4.76%||4:00 PM EDT||8.92M||9.48M||1.39B|
|CRON||Cronos Group Inc.||3.17||+0.12||+3.93%||4:00 PM EDT||1.88M||2.05M||1.18B|
|ACB||Aurora Cannabis Inc.||1.75||+0.14||+8.70%||4:00 PM EDT||13.18M||11.54M||346.98M|
|NBEV||NewAge, Inc.||0.2648||-0.00||-1.78%||4:00 PM EDT||1.40M||1.84M||38.88M|
|TGODF||The Green Organic Dutchman Holdings Ltd.||0.0711||+0.00||+4.48%||3:50 PM EDT||260.06k||286.31k||38.16M|
|CRBP||Corbus Pharmaceuticals Holdings, Inc.||0.2567||-0.01||-2.91%||4:00 PM EDT||2.63M||1.24M||32.15M|
|CANN||Trees Corporation||0.2275||+0.00||+0.22%||3:02 PM EDT||33.43k||45.37k||19.29M|
|MJ||ETFMG Alternative Harvest ETF||6.33||+0.18||+2.93%||4:00 PM EDT||727.34k||1.11M||-|
Many investors know that tobacco company Altria Group (NYSE: MO) owns a stake in beer giant Anheuser-Busch InBev -- a 10% stake, to be specific. Altria's decision to hold onto its stake has proven a genius move, and it's likely to pay handsomely down the road. Analysts believe Altria's 2022 earnings per share (EPS) will come in at roughly $4.86, valuing the stock at a price-to-earnings ratio (P/E) ratio of just over 9, and that's against a decade-median P/E of 17.5.
New drugs from Eli Lilly and Novo Nordisk have shown striking results in studies. If insurers step up to back them, the drugs—and the stocks—could take off.
Owen Bennett of Jefferies cuts estimates on major cannabis names as the economic slowdown and oversupply in some markets bite into projections.